BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hepatitis
,
Hypothalamus
,
DNA fingerprint
,
Rapamycin
,
rs3825942
,
DRD2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
human papillomavirus-16
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
ZFR2
CECR7
RNF212
CCDC88C
IRX4
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
FISCHER_DREAM_TARGETS
FAN_EMBRYONIC_CTX_NSC_2
ZHONG_PFC_C1_OPC
GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Primary skin fibroblasts overexpressing E6/E7 genes of HPV16, HPV18, HPV38b, HPV107 and HPV122
Explore Curated Studies Results
Literature
Most Relevant Literature
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins…
Expression of Daxx and HPV16 E6 and its significance in cervical lesions].
Roles of the PDZ-binding motif of HPV 16 E6 protein in oncogenic transformation of human cervical ke…
Molecular Probing of the HPV-16 E6 Protein Alpha Helix Binding Groove with Small Molecule Inhibitors…
A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligas…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolesce…
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolesce…
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ